Literature DB >> 18281307

Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.

Francisco José Pérez-Llarena1, Mónica Cartelle, Susana Mallo, Alejandro Beceiro, Astrid Pérez, Rosa Villanueva, Antonio Romero, Richard Bonnet, Germán Bou.   

Abstract

OBJECTIVES: In order to assess whether or not the Arg-276 of CTX-M-type enzymes is equivalent to the Arg-244 of IRT-TEM-derivative enzymes, we replaced the former with six different amino acids, some of them previously described as involved in resistance to beta-lactamase inhibitors in TEM-IRT derivatives. We also investigated the role of Arg276 in cefotaxime hydrolysis.
METHODS: By site-directed mutagenesis and by use of the bla(CTX-M-1) gene as template, Arg-276 was replaced with six different amino acids (Trp, His, Cys, Asn, Gly and Ser). MICs of beta-lactams alone and in combination with beta-lactamase inhibitors were established. The seven enzymes (CTX-M-1 wild-type and six derived mutants) were purified by affinity chromatography, and kinetic parameters (k(cat), K(m), k(cat)/K(m)) towards cefalotin and cefotaxime were determined. Clavulanic acid IC(50) values were also assessed with all enzymes.
RESULTS: No increase in MICs of beta-lactam/beta-lactamase inhibitor combination was detected with any of the six CTX-M-1-derived mutants, in agreement with the clavulanic acid IC(50) values. The MICs of cefotaxime were clearly lower for the Escherichia coli harbouring the Trp, Cys, Ser and Gly CTX-M-1 mutant enzymes than for CTX-M-1, and these enzymes showed a clearly reduced catalytic efficiency towards cefotaxime. As regards cefalotin, there was a moderate reduction in catalytic efficiency for Cys and His.
CONCLUSIONS: Arg-276 in CTX-M-type beta-lactamases is not equivalent to Arg-244 in IRT-type enzymes. Position Arg-276 appears to be important for cefotaxime hydrolysis in CTX-M-type enzymes, although different effects were obtained regarding the replaced amino acid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281307     DOI: 10.1093/jac/dkn031

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  18 in total

1.  Characterization of a novel IMP-28 metallo-β-lactamase from a Spanish Klebsiella oxytoca clinical isolate.

Authors:  Francisco José Pérez-Llarena; Ana Fernández; Laura Zamorano; Frédéric Kerff; Alejandro Beceiro; Belén Aracil; Emilia Cercenado; Elisenda Miro; Antonio Oliver; Jesús Oteo; Ferran Navarro; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2012-06-05       Impact factor: 5.191

2.  Roles of residues Cys69, Asn104, Phe160, Gly232, Ser237, and Asp240 in extended-spectrum beta-lactamase Toho-1.

Authors:  Akiko Shimizu-Ibuka; Mika Oishi; Shoko Yamada; Yoshikazu Ishii; Kiyoshi Mura; Hiroshi Sakai; Hiroshi Matsuzawa
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  A QM/MM study on the enzymatic inactivation of cefotaxime.

Authors:  Ignacio Lizana; Eduardo J Delgado
Journal:  J Mol Model       Date:  2017-06-20       Impact factor: 1.810

4.  New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.

Authors:  Ines Schneider; Anne Marie Queenan; Rumyana Markovska; Boyka Markova; Emma Keuleyan; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

5.  Analysis of the plasticity of location of the Arg244 positive charge within the active site of the TEM-1 beta-lactamase.

Authors:  David C Marciano; Nicholas G Brown; Timothy Palzkill
Journal:  Protein Sci       Date:  2009-10       Impact factor: 6.725

6.  Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis.

Authors:  Francisco José Pérez-Llarena; Frédéric Kerff; Olga Abián; Susana Mallo; María Carmen Fernández; Moreno Galleni; Javier Sancho; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2011-07-05       Impact factor: 5.191

7.  In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?

Authors:  Aida Ripoll; Fernando Baquero; Angela Novais; Mario J Rodríguez-Domínguez; Maria-Carmen Turrientes; Rafael Cantón; Juan-Carlos Galán
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

8.  OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Paul G Higgins; Francisco J Pérez-Llarena; Esther Zander; Ana Fernández; Germán Bou; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

9.  Molecular and biochemical characterization of the natural chromosome-encoded class A beta-lactamase from Pseudomonas luteola.

Authors:  Benoît Doublet; Frédéric Robin; Isabelle Casin; Laëtitia Fabre; Anne Le Fleche; Richard Bonnet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

10.  Excess positional mutual information predicts both local and allosteric mutations affecting beta lactamase drug resistance.

Authors:  George A Cortina; Peter M Kasson
Journal:  Bioinformatics       Date:  2016-07-27       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.